E. Gower, C. Estes, S. Blach, K. Razavi-shearer, and H. Razavi, Global epidemiology and genotype distribution of the hepatitis C virus infection, Journal of Hepatology, vol.61, issue.1, pp.45-57, 2014.
DOI : 10.1016/j.jhep.2014.07.027

J. Stanaway, A. Flaxman, M. Naghavi, C. Fitzmaurice, T. Vos et al., The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013, The Lancet, vol.388, issue.10049, pp.1081-88, 2016.
DOI : 10.1016/S0140-6736(16)30579-7

D. Thomas, Curing hepatitis C with pills: a step toward global control, The Lancet, vol.376, issue.9751, pp.1441-1483, 2010.
DOI : 10.1016/S0140-6736(10)61497-3

M. Lemoine and M. Thursz, Viral hepatitis: Scaling up HCV treatment in resource-limited countries, Nature Reviews Gastroenterology & Hepatology, vol.21, issue.4, pp.193-94
DOI : 10.1038/nrgastro.2015.31

C. Denkinger and M. Kessel, Diagnostics for hepatitis C: an urgent need for action, The Lancet Global Health, vol.3, issue.4, p.195
DOI : 10.1016/S2214-109X(15)70092-6
URL : http://doi.org/10.1016/s2214-109x(15)70092-6

J. Cohn, T. Roberts, V. Amorosa, M. Lemoine, and A. Hill, Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatment, Current Opinion in HIV and AIDS, vol.10, issue.5, pp.369-73, 2015.
DOI : 10.1097/COH.0000000000000180

A. Couroucé, L. Marrec, N. Bouchardeau, F. Razer, A. Maniez et al., Efficacy of HCV core antigen detection during the preseroconversion period, Transfusion, vol.39, issue.10, pp.1198-202, 2000.
DOI : 10.1046/j.1423-0410.2000.7820080.x

J. Peterson, G. Green, K. Iida, B. Caldwell, P. Kerrison et al., Detection of Hepatitis C Core Antigen in the Antibody Negative 'Window' Phase of Hepatitis C Infection, Vox Sanguinis, vol.9, issue.2, pp.80-85, 2000.
DOI : 10.1046/j.1423-0410.1998.7440213.x

S. Lee, J. Peterson, P. Niven, C. Bahl, E. Page et al., Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations, Vox Sanguinis, vol.39, issue.1, pp.19-23, 2001.
DOI : 10.1016/0168-8278(95)80043-3

M. Bouvier-alias, K. Patel, H. Dahari, S. Beaucourt, P. Larderie et al., Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatol Baltim Md, pp.211-229, 2002.

S. Chevaliez, A. Soulier, L. Poiteau, M. Bouvier-alias, and J. Pawlotsky, Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C, Journal of Clinical Virology, vol.61, issue.1, 2014.
DOI : 10.1016/j.jcv.2014.05.014

B. Heidrich, S. Pischke, F. Helfritz, I. Mederacke, J. Kirschner et al., Hepatitis C virus core antigen testing in liver and kidney transplant recipients, Journal of Viral Hepatitis, vol.32, issue.5, pp.769-79, 2014.
DOI : 10.1111/jvh.12204

M. Moini, M. Ziyaeyan, S. Aghaei, M. Sagheb, S. Taghavi et al., Hepatitis C virus (HCV) infection rate among seronegative hemodialysis

L. Duchesne, http://www.jiasociety.org/index patients screened by two methods; HCV core antigen and polymerase chain reaction, Journal of the International AIDS Society Hepat Mon, vol.2013, issue.6, pp.21446-9147, 2013.

J. Freiman, T. Tran, S. Schumacher, L. White, S. Ongarello et al., Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection, Annals of Internal Medicine, vol.165, issue.5, p.345, 2016.
DOI : 10.7326/M16-0065

B. Michelin, Z. Muller, E. Stelzl, E. Marth, and H. Kessler, Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA, Journal of Clinical Virology, vol.38, issue.2, pp.96-100, 2007.
DOI : 10.1016/j.jcv.2006.11.007

R. Njouom, M. Caron, G. Besson, G. Ndong-atome, M. Makuwa et al., Phylogeography, Risk Factors and Genetic History of Hepatitis C Virus in Gabon, Central Africa, PLoS ONE, vol.7, issue.8, p.42002, 2012.
DOI : 10.1371/journal.pone.0042002.t005
URL : https://hal.archives-ouvertes.fr/pasteur-00723648

M. Pepe, The statistical evaluation of medical tests for classification and prediction, 2003.

E. Nerrienet, R. Pouillot, G. Lachenal, R. Njouom, J. Mfoupouendoun et al., Hepatitis C virus infection in cameroon: A cohort-effect, Journal of Medical Virology, vol.74, issue.2, pp.208-222, 2005.
DOI : 10.1002/jmv.20343
URL : https://hal.archives-ouvertes.fr/hal-00542205

E. Durante-mangoni, L. Vallefuoco, R. Sorrentino, D. Iossa, E. Perna et al., Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection, Journal of Medical Virology, vol.55, issue.11, pp.1913-1931, 2013.
DOI : 10.1002/jmv.23672

T. Mixson-hayden, G. Dawson, E. Teshale, T. Le, K. Cheng et al., Performance of ARCHITECT HCV core antigen test with specimens from US plasma donors and injecting drug users, Journal of Clinical Virology, vol.66, pp.201515-201533
DOI : 10.1016/j.jcv.2015.02.015

C. Ottiger, N. Gygli, and A. Huber, Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples, Journal of Clinical Virology, vol.58, issue.3, pp.535-575, 2013.
DOI : 10.1016/j.jcv.2013.08.028

M. Medici, G. Furlini, A. Rodella, A. Fuertes, A. Monachetti et al., Hepatitis C virus core antigen: Analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay, Journal of Clinical Virology, vol.51, issue.4, pp.264-69, 2011.
DOI : 10.1016/j.jcv.2011.05.003

V. Thong, S. Akkarathamrongsin, A. Avihingsanon, A. Theamboonlers, Y. Poovorawan et al., Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV Hepatitis C core antigen testing: a reliable, quick, and potentially costeffective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection Clin Infect Dis Off Publ Infect Dis Soc Am HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferonalpha therapy Distinct features in natural history and outcomes of acute hepatitis C Breaking down barriers to care in Hepatitis C virus infection Dried blood spots: a tool to ensure broad access to Hepatitis C screening, diagnosis, and treatment monitoring Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen, virus RNA levels with respect to human immunodeficiency virus status, pp.73-79577, 1998.